Congenital Adrenal Hyperplasia, What’s NEW? - Novel Therapies for CAH
Presenter: Deborah Merke, MS, MD (NIH)
Relationship: Commercial Interest(s)
  Research Investigator: Diurnal.

Congenital Adrenal Hyperplasia, What’s NEW? - Chair
Presenter: Sharon Oberfield, MD (Columbia University Medical Center)
Relationship: Commercial Interest(s)
  Advisory Board Member: Myovant, Antares Pharma, Eton Pharmaceuticals. Research Investigator
  Neurocrine Bioscience, Spruce Bioscience.: Eli Lilly & Company.
  Grant Recipient: Applied Therapeutics, Inc., Boehringer Ingelheim, Eli Lilly & Company, Genentech, Inc., Hanmi, Janssen Research & Development Company, Metacrine, Novartis Pharmaceuticals, Novo Nordisk, Oramed, Pfizer, Inc., REMD Biotherapeutics Inc., Sanofi, VTV Therapeutics. Research Investigator

Congenital Adrenal Hyperplasia, What’s NEW? - Chair
Presenter: Dr. Richard Auchus, MD,PhD (University of Michigan)
Relationship: Commercial Interest(s)
  Consulting Fee: Corcept Therapeutics, Jansen Pharmaceuticals, Novartis Pharmaceuticals, Quest Diagnostics, Adrenas Therapeutics, Crinetics Pharmaceuticals, PhaseBio Pharmaceuticals, OMass Therapeutics, Recordati Rare Diseases, Strongbridge Biopharma, Lundbeck. Research Investigator
  Corcept Therapeutics, Novartis Pharmaceuticals, Neurocrine Biosciences, Spruce Biosciences.: Chiasma, Recordati - institutional-directed grant for multicentric trial, Strongbridge - institutional-directed grant for multicentric trial.

Congenital Adrenal Hyperplasia, What’s NEW? - Carry That Weight: What is the advantage for CYP21A2 Carriers?
Presenter: Anna Nordenstrom, MD PhD professor (Karolinska Institutet)
No relevant financial relationships

Congenital Adrenal Hyperplasia, What’s NEW? - Starting a Family - Eggs & Sperm in CAH Families
Presenter: Philippe Touraine, MD,PhD (GH Pitie Salpetriere)
No relevant financial relationships